1. Home
  2. ARAY vs GLO Comparison

ARAY vs GLO Comparison

Compare ARAY & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARAY
  • GLO
  • Stock Information
  • Founded
  • ARAY 1990
  • GLO 2006
  • Country
  • ARAY United States
  • GLO United States
  • Employees
  • ARAY N/A
  • GLO N/A
  • Industry
  • ARAY Medical/Dental Instruments
  • GLO Finance/Investors Services
  • Sector
  • ARAY Health Care
  • GLO Finance
  • Exchange
  • ARAY Nasdaq
  • GLO Nasdaq
  • Market Cap
  • ARAY 229.3M
  • GLO 193.7M
  • IPO Year
  • ARAY 2007
  • GLO N/A
  • Fundamental
  • Price
  • ARAY $1.34
  • GLO $5.40
  • Analyst Decision
  • ARAY
  • GLO
  • Analyst Count
  • ARAY 0
  • GLO 0
  • Target Price
  • ARAY N/A
  • GLO N/A
  • AVG Volume (30 Days)
  • ARAY 650.2K
  • GLO 170.5K
  • Earning Date
  • ARAY 08-13-2025
  • GLO 01-01-0001
  • Dividend Yield
  • ARAY N/A
  • GLO 11.38%
  • EPS Growth
  • ARAY N/A
  • GLO N/A
  • EPS
  • ARAY 0.01
  • GLO N/A
  • Revenue
  • ARAY $465,251,000.00
  • GLO N/A
  • Revenue This Year
  • ARAY $3.87
  • GLO N/A
  • Revenue Next Year
  • ARAY $0.09
  • GLO N/A
  • P/E Ratio
  • ARAY $205.58
  • GLO N/A
  • Revenue Growth
  • ARAY 8.06
  • GLO N/A
  • 52 Week Low
  • ARAY $1.14
  • GLO $4.08
  • 52 Week High
  • ARAY $2.95
  • GLO $5.18
  • Technical
  • Relative Strength Index (RSI)
  • ARAY 45.98
  • GLO 51.97
  • Support Level
  • ARAY $1.35
  • GLO $5.33
  • Resistance Level
  • ARAY $1.42
  • GLO $5.46
  • Average True Range (ATR)
  • ARAY 0.05
  • GLO 0.05
  • MACD
  • ARAY 0.00
  • GLO -0.01
  • Stochastic Oscillator
  • ARAY 33.33
  • GLO 50.00

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

About GLO Clough Global Opportunities Fund

Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.

Share on Social Networks: